Catalyst Funds Management Pty »

Palisade Bio shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $55k 31k 1.75

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Palisade Bio

Henderson Group
Octagon Capital Advisors
Perceptive Advisors
Ameriprise Financial
Commodore Capital
RA Capital Management
Franklin Resources
Eversept Partners
Goldman Sachs Group
Boxer Capital Management
Morgan Stanley
Adage Capital Partners GP
Dr. Jeffrey R. Jay, M.D.
Balyasny Asset Management
Federated Investors

View all funds holding Palisade Bio